FDA Drug Recalls

Recalls / Class II

Class IID-1387-2019

Product

Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg, Extended Release Tablets, USP, 30-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895. Made in India. UPC 0 50428 39131 0

Affected lot / code info
Lot: GKT0484B, EXP 04/2020

Why it was recalled

Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit

Recalling firm

Firm
Sun Pharmaceutical Industries, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
270 Prospect Plains Rd, N/A, Cranbury, New Jersey 08512-3605

Distribution

Quantity
9528 30 count units
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2019-06-05
FDA classified
2019-06-14
Posted by FDA
2019-06-26
Terminated
2021-01-08
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1387-2019. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls